Fig. 6From: Evaluation of bone marrow aspirates in patients with acute myeloid leukemia at day 14 of induction therapyOverall survival according to the qualitative evaluations of D14 BMA by two observers in patients (n = 55) treated with two or more cycles of intensificationBack to article page